silver has been researched along with trelstar in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Korkut, E; Schally, AV; Szepeshazi, K | 1 |
1 other study(ies) available for silver and trelstar
Article | Year |
---|---|
Decrease in the AgNOR number in Dunning R3327 prostate cancers after treatment with an agonist and antagonist of luteinizing hormone-releasing hormone.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Gonadotropin-Releasing Hormone; Histocytochemistry; Male; Nucleolus Organizer Region; Prostate; Prostatic Neoplasms; Rats; Silver; Triptorelin Pamoate | 1991 |